FDA notifications. FDA approves pediatric dosing for ritonavir.
D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D017277:Drug Approval; D017320:HIV Protease Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D017410:Practice Guidelines as Topic; D019438:Ritonavir / Q000008:administration & dosage* / Q000009:adverse effects; D014481:United States; D014486:United States Food and Drug Administration
D017320:HIV Protease Inhibitors; D019438:Ritonavir